SRPK2 and cancer: In general, cancer cells are frequently confronted with energy stress due to their rapid growth and limited oxygen supply, which inhibits the activity of mTOR signaling and potentially weakens the regulatory role of the BRD4-SRPK2-SRSF2 axis on ACSL3 expression.